JPS6153222A - インスリン作用増強剤 - Google Patents

インスリン作用増強剤

Info

Publication number
JPS6153222A
JPS6153222A JP59173939A JP17393984A JPS6153222A JP S6153222 A JPS6153222 A JP S6153222A JP 59173939 A JP59173939 A JP 59173939A JP 17393984 A JP17393984 A JP 17393984A JP S6153222 A JPS6153222 A JP S6153222A
Authority
JP
Japan
Prior art keywords
insulin
agent
insulin action
diabetes
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59173939A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0436138B2 (cg-RX-API-DMAC7.html
Inventor
Yoshiro Takeda
竹田　義朗
Hisakatsu Aragaki
新垣　尚捷
Akemichi Ueno
上野　明道
Yuzo Kawashima
川島　裕造
Tsutomu Uenoyama
上野山　勤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Factory Inc
Priority to JP59173939A priority Critical patent/JPS6153222A/ja
Publication of JPS6153222A publication Critical patent/JPS6153222A/ja
Publication of JPH0436138B2 publication Critical patent/JPH0436138B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP59173939A 1984-08-21 1984-08-21 インスリン作用増強剤 Granted JPS6153222A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59173939A JPS6153222A (ja) 1984-08-21 1984-08-21 インスリン作用増強剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59173939A JPS6153222A (ja) 1984-08-21 1984-08-21 インスリン作用増強剤

Publications (2)

Publication Number Publication Date
JPS6153222A true JPS6153222A (ja) 1986-03-17
JPH0436138B2 JPH0436138B2 (cg-RX-API-DMAC7.html) 1992-06-15

Family

ID=15969864

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59173939A Granted JPS6153222A (ja) 1984-08-21 1984-08-21 インスリン作用増強剤

Country Status (1)

Country Link
JP (1) JPS6153222A (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089602A (en) * 1988-02-08 1992-02-18 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Process for the manufacture of apolipoproteins from human blood plasma or serum

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089602A (en) * 1988-02-08 1992-02-18 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Process for the manufacture of apolipoproteins from human blood plasma or serum

Also Published As

Publication number Publication date
JPH0436138B2 (cg-RX-API-DMAC7.html) 1992-06-15

Similar Documents

Publication Publication Date Title
EP0309100B1 (en) Use of amylin or CGRP for the treatment of diabetes mellitus
JP4519324B2 (ja) 共有結合で架橋されたインスリンダイマー
FR2501692A1 (fr) Nouveau produit d'erythropoietine et procede pour sa preparation
ZA200306332B (en) Methods of treating diabetes mellitus
HK1000934B (en) Use of amylin or cgrp for the treatment of diabetes mellitus
ZA200406332B (en) ACC inhibitors.
JPS63303930A (ja) インシユリンおよびインシユリン誘導体の混合結晶
CN112342260A (zh) 一种利用脱脂南极磷虾粉制备降血糖肽的方法及其产品
JP3068656B2 (ja) 新規なペプチド及びアンジオテンシン変換酵素阻害ペプチド並びにそれらを含有する経口摂食組成物
US4526717A (en) Polypeptide having an action on the immunological system, processes for its isolation and purification, its use, agents containing this compound, and its cleavage products, their use and agents containing these products
JP5180074B2 (ja) サイモシンβ４誘導体及びその使用方法
JPS59122428A (ja) コレステロ−ル低下活性蛋白質
JP4477806B2 (ja) タマネギの有効成分を製造する方法、その製法によるタマネギの有効成分及び保健食品
Cunha-Melo et al. Acute gastric mucosal injury induced by toxins from Tityus serrulatus scorpion venom: a novel experimental model in the rat
JPS6153222A (ja) インスリン作用増強剤
EP0432400A2 (en) Pharmacologically active substance BPC, the process for its preparation and its use in the therapy
WO1992004368A1 (en) Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
US5000953A (en) Biologically active substance
US20100297267A1 (en) Compositions for diabetes treatment and prophylaxis
WO2018188565A1 (zh) 用于治疗代谢系统疾病的多肽及其组合物
JPS61171431A (ja) アミラ−ゼ阻害物質およびその製造法
CN113476591B (zh) 一种乳源多肽衍生物在制备糖尿病防治药物、保健品以及食品添加物中的应用
US3475534A (en) Methods of treating hyperinsulinism
AU1335599A (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
WO2019037393A1 (zh) 一种对glp-1受体具有高亲和性的多肽化合物及其制备方法和应用